Abstract: The invention of the present application intends to provide a work machine that can ensure high operability by preventing abrupt actuation of an actuator and a shock to a machine body by use of a bleed-off function at the time of starting of the actuator and that can improve the energy-saving performance by reducing a bleed-off flow rate after the starting of the actuator. For this purpose, a controller opens a bleed-off valve at a timing at which an operation device is being operated and before a flow rate of a hydraulic pump starts increasing, and closes the bleed-off valve at a timing at which the operation device is being operated and after the flow rate of the hydraulic pump has started increasing.

Abstract: A magnetic core material contains an Fe-based soft magnetic powder in which an inorganic insulating film 4b is formed on a surface of an Fe-based soft magnetic particle 4a, and an epoxy resin 4c containing a curing agent. The Fe-based soft magnetic particle 4a is formed of a pure iron powder or a low-alloy steel powder. A content of the epoxy resin containing the curing agent is 2 to 5 mass %. The epoxy resin is a mixture of a bisphenol A-type epoxy resin and a novolac-type epoxy resin.

Abstract: A solenoid valve includes: a cylindrical spool that has an annular groove in an outer surface and moves along an axial direction under a driving force generated by a current being applied to a solenoid part; a cylindrical sleeve that has a through-hole capable of communicating with the annular groove and houses the spool; and an urging member that urges the spool by an urging force acting in a direction opposite from a direction in which the driving force is generated. When no current is applied to the solenoid part, a part of the through-hole communicates with the annular groove. When a current is applied to the solenoid part, an area of communication between the through-hole and the annular groove increases as the spool moves under the driving force acting against the urging force.

Abstract: A solenoid valve includes: a cylindrical spool that has an annular groove in an outer surface and moves along an axial direction under a driving force generated by a current being applied to a solenoid part; a cylindrical sleeve that has a through-hole capable of communicating with the annular groove and houses the spool; and an urging member that urges the spool by an urging force acting in a direction opposite from a direction in which the driving force is generated. When no current is applied to the solenoid part, a part of the through-hole communicates with the annular groove. When a current is applied to the solenoid part, an area of communication between the through-hole and the annular groove increases as the spool moves under the driving force acting against the urging force.

Abstract: Provided are a drug, a cosmetic, etc. for promoting production of ceramide. Provided is a ceramide production promoter including a compound represented by the formula (1) or salts thereof as an active ingredient (in the formula, R1 represents a phosphono group or a hydrogen atom, R2 represents an alkyl group having 8 to 24 carbon atoms or an acyl group having 8 to 24 carbon atoms, and R3 represents an alkyl group having 1 to 24 carbon atoms when R1 represents a phosphono group or represents a phosphono group when R1 represents a hydrogen atom, or a salt thereof as an active ingredient.

Abstract: Provided are a drug, a cosmetic, etc. for promoting production of ceramide. Provided is a ceramide production promoter including a compound represented by the formula (1) or salts thereof as an active ingredient (in the formula, R1 represents a phosphono group or a hydrogen atom, R2 represents an alkyl group having 8 to 24 carbon atoms or an acyl group having 8 to 24 carbon atoms, and R3 represents an alkyl group having 1 to 24 carbon atoms when R1 represents a phosphono group or represents a phosphono group when R1 represents a hydrogen atom, or a salt thereof as an active ingredient.

Abstract: This invention relates to skin pore tighteners each of which comprises, as an active ingredient, a compound represented by the following formula: R1—OG ??(1) wherein R1 represents an alkyl or alkenyl group having 8 to 32 carbon atoms, and OG represents a residual group obtained by removing a hydrogen atom from a hydroxyl group of a polyhydric alcohol, monosaccharide or oligosaccharide at least one hydroxyl group of which has been sulfated or phosphatized, or a salt thereof, and also to skin elasticity improvers each of which comprises, as an active ingredient, a glyceryl ether derivative represented by the following formula: wherein R1 represents the same group as defined above, and X1 and X2 each independently represents a hydrogen atom, —SO3OH or —PO(OH)2 with the proviso that X1 and X2 are not hydrogen atoms at the same time, or a salt thereof.

Abstract: Provided are a drug, a cosmetic, etc. for promoting production of ceramide. Provided is a ceramide production promoter including a compound represented by the formula (1) or salts thereof as an active ingredient (in the formula, R1 represents a phosphono group or a hydrogen atom, R2 represents an alkyl group having 8 to 24 carbon atoms or an acyl group having 8 to 24 carbon atoms, and R3 represents an alkyl group having 1 to 24 carbon atoms when R1 represents a phosphono group or represents a phosphono group when R1 represents a hydrogen atom, or a salt thereof as an active ingredient.

Abstract: This invention relates to skin pore tighteners each of which comprises, as an active ingredient, a compound represented by the following formula: R1—OG ??(1) wherein R1 represents an alkyl or alkenyl group having 8 to 32 carbon atoms, and OG represents a residual group obtained by removing a hydrogen atom from a hydroxyl group of a polyhydric alcohol, monosaccharide or oligosaccharide at least one hydroxyl group of which has been sulfated or phosphatized, or a salt thereof, and also to skin elasticity improvers each of which comprises, as an active ingredient, a glyceryl ether derivative represented by the following formula: wherein R1 represents the same group as defined above, and X1 and X2 each independently represents a hydrogen atom, —SO3OH or —PO(OH)2 with the proviso that X1 and X2 are not hydrogen atoms at the same time, or a salt thereof.

Abstract: The present invention relates to a phosphorylated glyceryl ether aluminum salt represented by the general formula (1): (wherein R1 represents an alkyl or an alkenyl group with 8 to 32 carbon atoms; R2 represents a hydrogen atom, a phosphoric acid residue or —CH2CH(OR2)CH2OR1 (wherein R1 and R2 are the same as described above, provided that a repeated binding number is 4 at the most when R2 is —CH2CH(OR2)CH2OR1); X1 represents a hydrogen atom or a phosphoric acid residue, and at least one of X1 and R2 is a phosphoric acid residue; Y represents an alkali metal atom or an alkaline earth metal atom; m represents a number from 0.3 to 1, and n represents a number from 0 to 1), and an external dermatological agent containing the same. The compound has benefits such as an excellent pore contracting activity and also a good solubility in oil.

Abstract: A topical skin composition containing a dipeptide compound represented by formula (1) or a salt of the dipeptide: wherein R1 represents a hydrogen atom, an alkyl group, an alkanoyl group, or —CH(R6)COOR7 (wherein R6 represents a hydrogen atom or a lower alkyl group, and R7 represents a hydrogen atom, a lower alkyl group, a lower alkenyl group, or an aralkyl group); R2 represents a hydrogen atom or an alkyl group which may have a substituent; R3 represents a lower alkyl group or a phenyl group; R4 represents a hydrogen atom or a lower alkyl group, and may form a heterocyclic ring together with R5 and an adjacent nitrogen atom; R5 represents a hydrogen atom, an alkyl group which may have a substituent, or an aralkyl group which may have a substituent, and may form the heterocyclic ring together with R4; X represents —COOR8 (wherein R8 represents a hydrogen atom, a lower alkyl group, a lower alkenyl group, or an aralkyl group) or —SO3H; and n is an integer of 0-4; and a pharmaceutically acceptable carrier

Abstract: The present invention relates to a phosphorylated glyceryl ether aluminum salt represented by the general formula (1): (wherein R1 represents an alkyl or an alkenyl group with 8 to 32 carbon atoms; R2 represents a hydrogen atom, a phosphoric acid residue or —CH2CH(OR2)CH2OR1 (wherein R1 and R2 are the same as described above, provided that a repeated binding number is 4 at the most when R2 is —CH2CH(OR2)CH2OR1); X1 represents a hydrogen atom or a phosphoric acid residue, and at least one of X1 and R2 is a phosphoric acid residue; Y represents an alkali metal atom or an alkaline earth metal atom; m represents a number from 0.3 to 1, and n represents a number from 0 to 1), and an external dermatological agent containing the same. The compound has benefits such as an excellent pore contracting activity and also a good solubility in oil.

Abstract: At member registration step, a master transmits a certificate and a priority to a slave. The certificate indicates that the slave receiving it belongs to the same data synchronization group as the master. The priority is used to solve a data conflict. At data synchronization step, after it is determined that members belong to the same data synchronization group by the certificate, data synchronization processing is performed between arbitrary members in which an input device and a display device such as wrist watch are limited. Data synchronization does not require a specific server.

Abstract: At member registration step, a master transmits a certificate and a priority to a slave. The certificate indicates that the slave receiving it belongs to the same data synchronization group as the master. The priority is used to solve a data conflict. At data synchronization, after it is determined that members belong to the same data synchronization group by the certificate, data synchronization processing is performed between arbitrary members in which an input device and a display device such as a wrist watch are limited. Data synchronization does not require a specific server.

Abstract: This invention relates to skin pore tighteners each of which comprises, as an active ingredient, a compound represented by the following formula:

Abstract: A topical skin composition containing a dipeptide compound represented by formula (1) or a salt of the dipeptide: 1

Abstract: A topical skin composition containing a dipeptide compound represented by, formula (1) or a salt of the dipeptide: wherein R1 represents a, hydrogen atom, an alkyl group, an alkanoyl group, or —CH(R6)COOR7 (wherein R6 represents a hydrogen atom or a lower alkyl group, and R7 represents a hydrogen atom, a lower alkyl group, a lower alkenyl group, or an aralkyl group); R2 represents a hydrogen atom or an alkyl group which may have a substituent; R3 represents a lower alkyl group or a phenyl group; R4 represents a hydrogen atom or a lower alkyl group, and may form a heterocyclic ring together with R5 and an adjacent nitrogen atom; R5 represents a hydrogen atom, an alkyl group which may have a substituent, or an aralkyl group which may have a substituent, and may form the heterocyclic ring together with R4; X represents —COOR8 (wherein R8 represents a hydrogen atom, a lower alkyl group, a lower alkenyl group, or an aralkyl group) or —SO3H; and n is an integer of 0-4; and

Abstract: A broadcasting station creates a broadcast schedule for broadcasting advertisement information. An information providing apparatus receives the broadcast schedule through a communication network, changes the broadcast schedule based on advertisement rates for broadcasting the advertisement information, and creating a commercial program guide. The commercial program guide is transmitted through a communication network and received by an information storage apparatus. The information storage apparatus automatically records and stores the advertisement information from the broadcasting station based on the received commercial program guide. Also, commercials can be reproduced according to classifications in accordance with the commercial program guide. Thus, it is made possible to automatically record a commercial according to advertisement rates and to display a commercial as desired by a user.

Abstract: A continuous data server apparatus incorporating a plurality of buffer memory units for storing the continuous data read out by the data memory control units and to be given to the communication control unit, at least one buffer memory unit being provided dedicatedly for each combination of one data memory control unit group formed by at least one data memory control unit and one communication control unit group formed by at least one communication control unit. The apparatus may further incorporate a plurality of calculation units connected in series, where each calculation unit is connected between corresponding one data memory control unit group and at least one buffer memory unit, and carrying out a prescribed calculation processing.

Abstract: Disclosed herein is an external skin-care composition comprising hydroxycarboxylic acids or derivatives thereof represented by the general formulae (1), (2), and (3), or the salts thereof: ##STR1## wherein R.sup.1, R.sup.2, and R.sup.3 are each independently a hydroxyl group, an amino group or an alkoxyl group which may be substituted by 1-3 hydroxyl groups, l is a number of 7-11, m is a number of 6-10, and n is a number of 5-9. This composition exhibits an excellent moisturizing effect, moisturizes the skin, has a great effect in preventing skin roughness and shows excellent effects in enhancing the clear skin tone of the skin and reducing skin dullness, and is hence particularly useful for cosmetic skin-care compositions.